Garmin
Organization
Garmin Ltd. is an American multinational technology company that designs, develops, manufactures, markets, and distributes GPS-enabled products and other navigation, communication, sensor-based, and information products. Its products serve automotive, aviation, marine, outdoor recreation, and sports markets.
What experts have said about Garmin
5 statements · 4 positive · 1 mixed
Garmin shares rose 370% after Apple Watch fears emerged.
“Since then, they've risen 370%.”
Open the episode · Investor Insights: Unveiling Market Movers & Bonkers BargainsListen at 4:02
Garmin remains successful through sustained innovation and new-product investment.
“This company is doing just fine. It's got this history of innovation, keeps on plowing money into new products.”
Open the episode · Investor Insights: Unveiling Market Movers & Bonkers BargainsListen at 4:15
Garmin’s innovation history means investors should not dismiss the company.
“It's got phenomenal history of innovation, and so don't write it off.”
Open the episode · Investor Insights: Unveiling Market Movers & Bonkers BargainsListen at 4:33
Garmin quarterly revenue increased 24% to $1.59 billion.
“Revenue in the last quarter was up 24% to $1.59 billion.”
Open the episode · Investor Insights: Unveiling Market Movers & Bonkers BargainsListen at 4:40
Garmin must invest heavily and continuously to remain competitive in its product markets.
“Garmin, another one of the stocks you were talking about, the maker of the smartwatches and GPS track watches and outdoor leisure products, is a case in point. It's having to invest like mad.”
Open the episode · IC038 AIM Market and Budget ImpactsListen at 12:20
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
4 episodes featuring Garmin
The Shawn Ryan Show
Craighead recounts Nairobi rescue amid faith and legal battle
The episode pairs a detailed account of a terrorist siege and civilian rescue with competing claims about faith, politics, trauma, and who gets to tell the story.
Sep 14, 2026 · 5h 22m
The Shawn Ryan Show
Koniver challenges medicine’s shortcuts with personalized longevity care
The conversation tests where individualized health optimization can offer useful alternatives—and where emerging therapies remain uncertain, experimental, or overpromoted.
Aug 13, 2026 · 2h 20m
Investor's Champion Podcast
Investors weigh AI bets, AIM bargains and pension policy
The discussion connects portfolio decisions with a broader question: should policy redirect pension capital, or improve the conditions facing UK companies?
Mar 16, 2025 · 27 min
Investor's Champion Podcast
Budget tests AIM’s case against global growth stocks
The episode weighs whether tax advantages and UK-market access can offset weaker investment conditions and the pull of international winners.
Nov 2, 2024 · 14 min